Silvercrest Asset Management’s Axcelis ACLS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-5,302
Closed -$556K 823
2024
Q3
$556K Buy
5,302
+890
+20% +$104K ﹤0.01% 638
2024
Q2
$627K Buy
+4,412
New +$509K ﹤0.01% 684
2023
Q1
Sell
-30,063
Closed -$2.39M 794
2022
Q4
$2.39M Sell
30,063
-13,188
-30% -$929K 0.02% 446
2022
Q3
$2.62M Sell
43,251
-1,001
-2% -$64.7K 0.02% 415
2022
Q2
$2.43M Buy
+44,252
New +$2.56M 0.02% 438

Other funds holding ACLS

Silvercrest Asset Management's ACLS Position: Q4 2024 in Review

Silvercrest Asset Management sold out of Axcelis (ACLS) in Q4 2024, closing a stake of 5,302 shares — an estimated $556K sold.

Silvercrest Asset Management first reported a position in ACLS in Q2 2022 and held it in 5 quarters. The position peaked at $2.62M in Q3 2022. 324 funds tracked by Wall St. Rank hold ACLS as of Q4 2024.

  • Silvercrest Asset Management reported no remaining Axcelis position as of Q4 2024 after selling out during the quarter.
  • Silvercrest Asset Management sold 5,302 Axcelis shares in Q4 2024, an estimated $556K.
  • Silvercrest Asset Management first reported a position in Axcelis in Q2 2022 and held it in 5 quarters.
  • Silvercrest Asset Management's Axcelis position peaked at $2.62M in Q3 2022.
  • 324 funds tracked by Wall St. Rank held Axcelis as of Q4 2024.

Based on Silvercrest Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.